CTOs on the Move


 
Someone to talk to
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.sibly.com
  • 2395, Broadway St
    Redwood City, CA USA 94063
  • Phone: 800.784.2433

Executives

Name Title Contact Details

Similar Companies

Buckeye Pharmaceuticals

Buckeye Pharmaceuticals is a Beachwood, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Florida Emergency Physicians

Florida Emergency Physicians is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Maitland, FL. To find more information about Florida Emergency Physicians, please visit www.psrinc.net

Bert Fish Medical Center

Bert Fish Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Bert Fish Medical Center is based in New Smyrna Beach, FL. You can find more information on Bert Fish Medical Center at www.bertfish.com

Vericred

Vericred, Inc. is a healthcare data services company, operating at the intersection of health insurance and technology. Vericred serves companies who are transforming today`s healthcare experience, from care management to finding the right insurance plan. Its datasets are the foundation on which the healthcare industry builds innovative solutions. Vericred`s health insurance data platform, which is comprised of plan design and rate data, provider-network data and formulary data, offers a solution to an industry plagued by highly fragmented, rapidly changing data that currently exists in non-standard and non-structured formats.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.